CN103980317B - Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof - Google Patents

Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof Download PDF

Info

Publication number
CN103980317B
CN103980317B CN201410242328.4A CN201410242328A CN103980317B CN 103980317 B CN103980317 B CN 103980317B CN 201410242328 A CN201410242328 A CN 201410242328A CN 103980317 B CN103980317 B CN 103980317B
Authority
CN
China
Prior art keywords
bipyridyl
ruthenium complex
reaction
tetradentate ligandses
tetradentate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410242328.4A
Other languages
Chinese (zh)
Other versions
CN103980317A (en
Inventor
周其林
李威
谢建华
王立新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN201410242328.4A priority Critical patent/CN103980317B/en
Publication of CN103980317A publication Critical patent/CN103980317A/en
Application granted granted Critical
Publication of CN103980317B publication Critical patent/CN103980317B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a dipyridyl tetradentate ligand ruthenium complex as well as a preparation method of the complex and application of the complex to a reaction for hydrogenating ester compounds into alcohol compounds. A method for catalytically hydrogenating the ester compounds into the alcohol compounds by using the dipyridyl tetradentate ligand ruthenium complex is characterized by comprising the following steps: by taking 0.001mol% to 0.3mol% of the dipyridyl tetradentate ligand ruthenium complex based on the ester compounds, as a catalyst, adding 1mol%-10mol% of alkali based on the ester compounds, and catalytically hydrogenating the ester compounds into the corresponding alcohol compounds under the conditions that the temperature is 25-100 DEG C and the hydrogen pressure is 1-10MPa. The dipyridyl tetradentate ligand ruthenium complex is convenient to prepare, stable in structure and excellent in catalytic activity in hydrogenation reaction of the ester compounds. According to the preparation method, the shortcomings of requirements on high-temperature high-pressure reaction conditions and high catalyst consumption in an existing homogeneous or non-homogeneous catalytic hydrogenation system of the ester compounds are overcome, the catalyst consumption is low, the reaction conditions are mild, the reaction selectivity is good, and the economy and the safety of a production system are improved.

Description

Bipyridyl tetradentate ligandses ruthenium complex and its preparation method and application
Technical field
The present invention relates to a kind of new bipyridyl tetradentate ligandses ruthenium complex and preparation method thereof and in ester type compound hydrogen Turn to the application in alcohol compound reaction.
Background technology
The important reaction that alcohol compound is in organic synthesiss is prepared in ester type compound reduction, no matter in basic scientific research Or important meaning is had on commercial production.Ester type compound be reduced to alcohol compound in the lab commonly use be hydrogen Change the negative hydrogen reagents such as aluminum lithium, and these negative hydrogen reagents can produce substantial amounts of inorganic wastes in post processing, and these are active Negative hydrogen reagent can bring potential safety hazard in a large amount of use, limits its application in commercial production.Using catalytic hydrogenation also Former ester type compound is a kind of method of high atom economy for alcohol compound, therefore for the hydrogenation of ester type compound The development of catalyst causes the extensive concern of people.
At present, the heterogeneous catalysis hydrogenation of ester type compound generally requires the harsh conditions of High Temperature High Pressure, such as cu-cr or The catalyst such as cu-zn-cr are the catalyst being used in ester type compound hydrogenation earliest, but during these catalyst hydrogenations Generally require very high temperature (200~300 DEG C) and Hydrogen Vapor Pressure (20~30mpa).Chinese patent cn103566933a is open A kind of using silicon dioxide carried cu catalyst, add mg, one of zn, ni, zr element or mg-zn, mg-zr conduct Auxiliary agent, is 200~270 DEG C in reaction temperature, the method that Hydrogen Vapor Pressure prepares ethanol for catalytic hydrogenation acetate under the conditions of 3mpa, Acetic acid ester conversion rate 98%, ethanol selectivity 98%.Cn102976892a disclose a kind of using mesoporous molecular sieve carried cu Catalyst, the oxide adding at least one element in la, ce is that auxiliary agent is 220 DEG C in reaction temperature, and Hydrogen Vapor Pressure is The method that under the conditions of 3mpa, catalytic hydrogenation acetate prepares ethanol, acetic acid ester conversion rate 98.5%, ethanol selectivity 99.6%. Cn102649694a discloses a kind of cu catalyst of the composite carrier load of use silicon oxide and aluminium oxide, adds re, w gold Belong to element and its oxide as auxiliary agent, be 170~270 DEG C in reaction temperature, Hydrogen Vapor Pressure is urged under the conditions of 1.5~10mpa Change the method that hydrogenation oxalate prepares ethylene glycol, the conversion ratio of oxalate can reach 100%, and the selectivity of ethylene glycol is more than 95%.Cn101602005b disclose a kind of using silicon dioxide carried pd-cu bimetallic catalyst reaction temperature be 120 ~180 DEG C, Hydrogen Vapor Pressure is catalytic hydrogenation 3 under the conditions of 1~5mpa, and 3- acid dimethyl methyl ester synthesizes 3,3- dimethyl butyrate alcohol Method, the yield 95.6% of 3,3- dimethyl butyrate alcohols.Cn1097038c discloses one kind and is used containing cu, mn, al as basic The catalyst of composition is 150~230 DEG C in reaction temperature, and Hydrogen Vapor Pressure is by adipate ester and 6- hydroxyl under the conditions of 1~7mpa Caproic acid ester hydrogenation prepare 1,6- hexanediol method, feed stock conversion 100%, generate 1,6- hexanediol selectivity be higher than 95%.Cn1974510a discloses a kind of ru, rh or ru-zn of use zirconia-supported, ru-co, ru-sn catalyst anti- Temperature is answered to be 100~150 DEG C, Hydrogen Vapor Pressure is the method that the multiple fatty acid ester of catalytic hydrogenation prepares alcohol under the conditions of 3~7mpa, former Material conversion ratio is 75.0~99.5%, and selectivity of product is 68.2~99.5%.These heterogeneous catalysis hydro genation system are generally deposited In the problem of severe reaction conditions (for example: high temperature, high pressure), lead to production cost high, be unfavorable for large-scale production.
No matter the development of the homogeneous catalytic hydrogenation catalyst of ester type compound is obtained in academia or in industrial quarters Concern.Recent years, more research is obtained based on the ester type compound homogeneous catalytic hydrogenation catalyst of ruthenium, corresponding report May refer to nearest survey article (acs catalysis2012,2,1718-1741;org.process Res.dev.2014,18,289-302) and wherein literature cited.Industrial quarters also has more ester type compound homogeneous catalytic hydrogenation Patent report, such as ep1970360a1 discloses and a kind of prepares alcohol using double ruthenium complex catalysed hydrogenation of carboxylic acid esters of phosphine diamine Method, wherein for aromatic carboxylic acid esters such as essence of Niobe the s/c ratio of the amount of the material of catalyst (substrate with)= Under the conditions of 500,100 DEG C and 5mpa Hydrogen Vapor Pressure, reaction 8h can obtain benzyl alcohol with 97.7% yield, for fatty acid ester such as In s/c=500,100 DEG C and 5mpa Hydrogen Vapor Pressure conditioned response 16h can obtain capryl alcohol with 92.9% yield to methyl caprylate, right In lactone such as Phthalide in s/c=500,100 DEG C and 5mpa Hydrogen Vapor Pressure conditioned response 18h can obtain adjacent benzene with 98.5% yield Dimethanol.Ep2141142a1 discloses a kind of method using the ruthenium complex catalysed hydrogenation of carboxylic acid esters of three Phosphine ligands to prepare alcohol, its In for aromatic carboxylic acid esters such as essence of Niobe in s/c=632, under the conditions of 100 DEG C and 4mpa Hydrogen Vapor Pressure, reaction 15h is permissible 54.1% yield obtains benzyl alcohol, for fatty acid ester such as methyl lactate in s/c=16,377,120 DEG C and 4mpa hydrogen pressure Under the conditions of power, reaction 16h can obtain 1,2-PD with 88.5% yield, for lactone such as gamma-butyrolacton in s/c=679, Under the conditions of 100 DEG C and 4mpa Hydrogen Vapor Pressure, reaction 13h can obtain BDO with 69.0% yield.jp2012224600a Disclose one kind and prepare 2- (l- Herba Menthae using pnp tri- tooth pincer ligand ruthenium complex catalysed hydrogenation l- Herba Menthae ethoxyacetic acid methyl ester Epoxide) ethanol method, in s/c=2000, under the conditions of 85 DEG C and 4.5mpa Hydrogen Vapor Pressure, reaction 6h can be obtained with 90% yield To target product.Us20100125144 discloses one kind using the preparation of pnnp tetradentate ligandses ruthenium complex catalysed hydrogenation of carboxylic acid esters The method of alcohol, wherein for aromatic carboxylic acid esters such as essence of Niobe in s/c=2000,100 DEG C and 5mpa Hydrogen Vapor Pressure condition Reaction 2.5h can obtain 99% conversion ratio, for fatty acid ester such as methyl caprylate in s/c=2000,100 DEG C and 5mpa hydrogen Atmospheric pressure conditioned response 2.5h can obtain 97% conversion ratio, for such as third nonalactone of lactone in s/c=2000,100 DEG C 94% conversion ratio can be obtained with 5mpa Hydrogen Vapor Pressure conditioned response 2.5h.W02006106483a1 discloses one kind and uses phosphine The method that the ruthenium complex catalysed hydrogenation of carboxylic acid esters of amine ligand prepares alcohol, wherein for aromatic carboxylic acid esters such as essence of Niobe in s/ C=2000, the 100 DEG C and 5mpa Hydrogen Vapor Pressure conditioned response 2.5h conversion ratios that can obtain 98%, for example pungent for fatty acid ester , in s/c=2000, the 100 DEG C and 5mpa Hydrogen Vapor Pressure conditioned response 2.5h conversion ratios that can obtain 86%, for interior for sour methyl ester Such as third nonalactone of ester in s/c=2000, the 100 DEG C and 5mpa Hydrogen Vapor Pressure conditioned response 2.5h conversions that can obtain 98% Rate.Wo2012052996a2 discloses a kind of ruthenium complex catalysed hydrogenation of carboxylic acid esters of use pnn tri- tooth pincer ligand and prepares alcohol Method, wherein for methyl formate in s/c=5000, under the conditions of 110 DEG C and 5mpa Hydrogen Vapor Pressure, reaction 14h can be with 93.7% Yield obtains methanol, and for dimethyl carbonate in s/c=5000, under the conditions of 110 DEG C and 5mpa Hydrogen Vapor Pressure, reaction 14h is permissible 87.6% yield obtains methanol, for hexyl hexanoate in s/c=4000, reacts 16h under the conditions of 110 DEG C and 5mpa Hydrogen Vapor Pressure Hexanol can be obtained with 82.1% yield.
On the whole, the homogeneous catalytic hydrogenation of ester type compound can be carried out under conditions of relatively gentle, but mostly Number report reaction temperatures remain a need for 100 DEG C and more than, the large usage quantity of catalyst, thus increased production cost, be unfavorable for Industrialized production.Therefore, develop efficient ester type compound homogeneous catalytic hydrogenation catalyst to be particularly important.
Content of the invention
It is an object of the invention to proposing a kind of new bipyridyl tetradentate ligandses ruthenium complex and preparation method thereof and in ester Class hydrogenation of compounds is the application in alcohol compound reaction.Will be generated in-situ to bipyridyl tetradentate ligandses and metal ruthenium precursor Pyridine tetradentate ligandses ruthenium complex solution or directly using synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex as catalysis Agent is applied in the reaction that alcohol compound is prepared in ester type compound hydrogenation.The bipyridyl tetradentate ligandses ruthenium complex system of the present invention Standby convenient, Stability Analysis of Structures, show excellent catalysis activity in esters chemical combination hydrogenation.Instant invention overcomes existing esters Compound is homogeneous or heterogeneous catalysis hydro genation system needs high-temperature high-voltage reaction condition and the shortcoming of high catalyst consumption, catalyst Consumption is little, and reaction condition is gentle, and the selectivity of reaction is good, improves economy and the safety of production system.
New bipyridyl tetradentate ligandses provided by the present invention have a general structure as shown in i:
Wherein, coordinating group l1And l2Can be independently selected from phosphorous (pr1r2), nitrogen (nr1r2) or sulfur (sr) group, coordination Group l1、l2Can be identical, also can be different.
r、r1And r2Can be independently selected from c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthalene The group that base, heteroaryl, benzyl etc. have no adverse effect to reaction.Substituent group on described substituted phenyl is c1~c8Alkyl, c3~c8The group that cycloalkyl, phenyl, alkoxyl and halogen etc. have no adverse effect to reaction, substituent group quantity is 1~5;Described Heteroaryl be furyl, thienyl or pyridine radicals etc.;r1、r2Can be identical, also can be different.r1、r2Can and be c3~c8Fat Ring or aromatic rings.
x1、x2Can be independently selected from h, c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthalene The group that base, heteroaryl, benzyl, halogen etc. have no adverse effect to reaction;Substituent group on described substituted phenyl is c1~c8 Alkyl, c3~c8Cycloalkyl, phenyl, alkoxyl and halogen etc. to the group that has no adverse effect of reaction, substituent group quantity is 1~ 5;Described heteroaryl is furyl, thienyl or pyridine radicals etc.;M=0~3, n=0~3;When m >=2, two adjacent x1 Can and be c3~c8Cycloaliphatic ring or aromatic rings;When n >=2, two adjacent x2Can and be c3~c8Cycloaliphatic ring or aromatic rings;x1、 x2Can be identical, also can be different;
Alternatively, above-described c1~c8Alkyl is methyl, ethyl, n-pro-pyl, isopropyl, normal-butyl, tert-butyl group etc.; Described c3~c8Cycloalkyl is cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl etc.;Described alkoxyl be methoxyl group, ethyoxyl, Positive propoxy, isopropoxy, n-butoxy, tert-butoxy etc..
The present invention is well known to those of ordinary skill in the art, here and hereafter no longer do in detail with regard to the definition of group Explanation.
Alternatively, bipyridyl tetradentate ligandses include shown in following structural formula:
The in-situ preparation that the present invention provides or synthetically prepared bipyridyl tetradentate ligandses ruthenium complex have as shown in ii General structure:
Wherein, l1、l2、x1、x2, m, n definition identical with described in formula i;Y, z are h or other complex anion such as halogen (cl、br、i)、clo4、pf6、bph4、b(c6f5)4、bf4、bh4、ocor、ococf3、oso2r、oso2cf3、cn、or、nr2、sr;r For h, c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthyl, heteroaryl, benzyl etc. are to reaction The group having no adverse effect, the substituent group on described substituted phenyl is c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, alcoxyl The group that base and halogen etc. have no adverse effect to reaction, substituent group quantity is 1~5;Described heteroaryl is furyl, thiophene Base or pyridine radicals etc.;Y, z can be identical, also can be different.
Alternatively, y, z are identical halogen: cl, br, i.
Y in formula ii, z are that bipyridyl tetradentate ligandses ruthenium complex during identical halogen (cl, br, i) can be by such as lower section Method is by bipyridyl tetradentate ligandses and metal ruthenium precursor in-situ preparation or synthetically prepared:
1) in-situ preparation: in dichloromethane, oxolane, toluene, n, n- dimethylformamide, dimethyl sulfoxide etc. are organic molten In agent, the bipyridyl tetradentate ligandses of the present invention of metal ruthenium precursor and amount 1.0~1.5 times amount with respect to ruthenium atom material, React 4~16 hours at 25~120 DEG C, you can obtain bipyridyl tetradentate ligandses ruthenium complex solution.Or
2) synthetically prepared: in dichloromethane, oxolane, toluene, n, n- dimethylformamide, dimethyl sulfoxide etc. are organic molten In agent, the bipyridyl tetradentate ligandses of the present invention of metal ruthenium precursor and amount 1.0~1.5 times amount with respect to ruthenium atom material, React 4~16 hours at 25~120 DEG C, solution rotating is evaporated to original volume~1/10.The solution of concentration is added under agitation The poor solvent such as ether or normal hexane, separates out dark purple black solid, vacuum filtration, is washed with poor solvents such as ether or normal hexane Filter cake, obtains solid bipyridyl tetradentate ligandses ruthenium complex after filter cake vacuum drying.
Described metal ruthenium precursor can be rucl3·nh2o、[rucl2(co)3]2、[ru(cod)cl2]n、[ru(nbd) cl2]n、[rucl2(benzene)]2、[rubr2(benzene)]2、[rui2(benzene)]2、[rucl26-p-cymene)]2、 [rubr26-p-cymene)]2、[rui26-p-cymene)]2、[rucl2(mesitylene)]2、[rubr2 (mesitylene)]2、[rui2(mesitylene)]2、rucl2(pph3)3, rubr2(pph3)3、rui2(pph3)3、rucl2 (dmso)4, wherein: cod=1,5- cyclo-octadiene, nbd=2,5- norbornadiene, dmso=dimethyl sulfoxide) etc..
Alternatively, in-situ preparation or synthetically prepared bipyridyl tetradentate ligandses ruthenium complex include shown in following structural formula:
Y in formula ii, z can be by y for bipyridyl tetradentate ligandses ruthenium complex when h or other complex anion, and z is identical Halogen (cl, br, i) when bipyridyl tetradentate ligandses ruthenium complex and the sodium hydride of respective amount, Sodium Acetate Trihydrate, sodium perchlorate, four The inorganic salts such as phenyl boron sodium, Silver Trifluoroacetate exchange anion in-situ and generate and obtain corresponding bipyridyl tetradentate ligandses ruthenium complex Solution or synthetically prepared obtain corresponding solid bipyridyl tetradentate ligandses ruthenium complex.
The present invention will be molten with metal ruthenium precursor generated in-situ bipyridyl tetradentate ligandses ruthenium complex for bipyridyl tetradentate ligandses Liquid or synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex are applied to ester type compound catalytic hydrogenation as catalyst and are In the reaction of alcohol compound, the ester type compound that is suitable for can be aliphatic carboxylic acid esters, aromatic carboxylic acid esters, formic acid esters, Carbonic ester and lactone etc., can contain one or more ester groups, can be with the substituent group arbitrarily not affecting hydrogenation.
Described ester type compound is as shown in formula iii:
Wherein, ra、rbCan be independently selected from c1~c30Alkyl, c3~c30Cycloalkyl, c2~c30Thiazolinyl, c3~c30Cycloalkenyl group, Aryl etc., can contain in these groups does not arbitrarily affect the substituent group of hydrogenation, ra、rbCan be identical, also can be different;ra、 rbCan be connected and form the c of ring-type4~c30Lactone, lactonic ring can contain arbitrarily does not affect the replacement of hydrogenation Base, on lactonic ring, the carbon atom of correct position can be replaced by hetero atoms such as o, n, s, lactonic ring can be monocyclic or Multi-ring, described lactone can be saturation lactone or unsaturated lactone.
Described alcohol compound is as shown in formula iv-a, iv-b:
ra、rbDefinition identical with described in formula iii.Work as ra、rbBe not connected when described in alcohol compound such as iv-a, Shown in iv-b;Work as ra、rbAlcohol compound described in when connected is the dihydroxylic alcohols of gained after corresponding lactone reduction;When hydrogenation is used Ester type compound in containing multiple ester group when, the alcohol compound of gained is corresponding polyhydric alcohol.
The non-limiting examples of ester type compound include essence of Niobe, ethyl acetate, ethylene carbonate, levulic acid Methyl ester, dimethyl succinate, gamma-butyrolacton, gamma-valerolactone, Alpha-Methyl-gamma-butyrolacton, methyl glycollate, methyl lactate, first Ethoxyacetic acid methyl ester, methyl laurate, methyl stearate, trilaurin, glyceryl tristearate, dimethyl oxalate., 1,2- phthalic acid methyl ester, 1,3- phthalic acid methyl ester, methyl caproate, hexyl hexanoate etc..
The method of the catalytic hydrogenation application to ester type compound for the present invention comprises the steps:
Under argon or nitrogen are protected, catalyst is bipyridyl tetradentate ligandses ruthenium complex (generated in-situ bipyridyl Tetradentate ligandses ruthenium complex solution or synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex) and alkali addition reactor inner tube In, add substrate to be dissolved in the solution of coordinative solvent, tighten reactor and with the careful displacement of hydrogen 3~5 times, adjust Hydrogen Vapor Pressure to After desirable pressure, stirring reaction no longer changes to pressure at appropriate temperatures, and reactor is recovered room temperature, slowly discharges residual hydrogen Gas.Product carries out separating-purifying by the conventional organic compound purification process such as column chromatography, distillation.
It is alcohol compound method that the present invention uses bipyridyl tetradentate ligandses ruthenium complex catalysed hydrogenation ester type compound Be characterised by: catalyst amount be substrate materials amount 0.001~0.3mol%, alkali consumption be substrate materials amount 1~ 10mol%, Hydrogen Vapor Pressure 1~10mpa, reaction temperature is 25~100 DEG C, and the response time is 2~64 hours.
The present invention can be carried out to the catalytic hydrogenation of ester type compound under condition of no solvent, but preferably uses solvent.Institute With the non-limiting examples of solvent be oxolane, in the organic solvent such as ether, 2- methyltetrahydrofuran, isopropanol, toluene A kind of or wherein several mixed solvents.
The present invention is Feldalat NM, Sodium ethylate, isopropyl to the non-limiting examples of ester type compound alkali used by catalytic hydrogenation Sodium alkoxide, sodium tert-butoxide, Feldalat KM, potassium ethoxide, potassium isopropoxide, potassium tert-butoxide etc..Alkali used can be added directly in reactor In pipe or be dissolved in coordinative solvent and be added in reactor inner tube.
The present invention will be molten with metal ruthenium precursor generated in-situ bipyridyl tetradentate ligandses ruthenium complex for bipyridyl tetradentate ligandses Liquid or directly synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex is applied to ester type compound hydrogenation as catalyst Prepare in the reaction of alcohol compound.The bipyridyl tetradentate ligandses ruthenium complex preparation of the present invention is convenient, and Stability Analysis of Structures, in esters Excellent catalysis activity, good reaction selectivity is shown, yield is high in chemical combination hydrogenation.Instant invention overcomes existing esters Compound is homogeneous or heterogeneous catalysis hydro genation system needs high-temperature high-voltage reaction condition and the shortcoming of high catalyst consumption, and catalyst is used Amount is little, and reaction condition is gentle, and reaction temperature and pressure are far below other homogeneous or heterogeneous catalysis systems, the selectivity of reaction Good, improve economy and the safety of production system, have broad application prospects.
Specific embodiment
Following non-limiting examples can make those of ordinary skill in the art that the present invention is more fully understood, but not with Any mode limits the present invention.The experimental technique of unreceipted actual conditions in embodiment, generally according to normal condition and handbook Described in condition, or according to the condition proposed by manufacturer;Material used, reagent etc., if no special instructions, all can be from Commercial sources obtain.
All Air-sensitive compounds weigh and on vacuum line all in mbraun labstar argon atmosphere glove box In strict accordance with the technical operation of standard schlenk.1h nmr、13c nmr、31P nmr nuclear magnetic resoance spectrum is respectively by bruker av400 Nuclear magnetic resonance analyser (operating frequency is respectively 400mhz, 101mhz and 162mhz) measures, and the unit of chemical shift is ppm,1h Nmr spectrum tetramethylsilane as internal standard,13C nmr composes with listed deuterated solvent as internal standard,31Pnmr spectrum uses 85% h3po4As external standard;High resolution mass spectrum is measured by apexii type ft-icr mass spectrograph, with esi (electron spray ionisation) or maldi (base The attached ionization of matter assisted laser desorption) it is ion source;Elementary analysiss are measured by elementar vario el elemental analyser;Monocrystalline Diffraction is measured by rigaku007saturn70 single crystal diffractometer;Gas chromatographic analysiss use agilent7890a gas chromatograph.
Embodiment 1
The preparation of ligand 1
2- methyl -6- (tri-n-butyl tin base) pyridine (8): equipped with constant pressure funnel, turned welt plug and magnetic stir bar Two mouthfuls of round-bottomed bottles of 500ml of dried and clean in add 2- methyl -6- bromopyridine (20.0g, 116mmol), system is replaced into Argon atmosphere, adds anhydrous tetrahydro furan (200ml).By system liquid nitrogen-acetone cryostat temperature control to -78 DEG C, dropwise Deca is being just The hexane solution (2.4m, 56.0ml, 134mmol) of butyl lithium, time for adding is 30 minutes.Drip and finish, continue to stir at -78 DEG C 2 hours.With syringe in system dropwise Deca tri-n-butyltin chloride (45.4g, 140mmol), time for adding is 30 minutes. Drip and finish, continue to stir 30 minutes at -78 DEG C, clear-cutting forestland is stirred at room temperature reaction overnight (14 hours).By system rotary evaporation Instrument precipitation, residue with diethyl ether (300ml) dilutes, and is washed with water (200ml) and saturated aqueous common salt (200ml) successively, organic faciess With anhydrous sodium sulfate drying, stand.Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, residue vacuum distillation, collects 145 DEG C/0.4mmhg fraction, obtains nearly colourless oil liquid product 40.0g, yield: 90%.1H nmr (400mhz, cdcl3)δ 7.36 (t, j=7.5hz, 1h), 7.18 (d, j=7.4hz, 1h), 6.95 (d, j=7.6hz, 1h), 2.54 (s, 3h), 1.69- 0.76 (m, 27h).13C nmr (101mhz, cdcl3) δ 173.11 (s), 158.70 (s), 133.40 (s), 129.48 (s), 121.62 (s), 29.22 (s), 27.47 (s), 24.98 (s), 13.82 (s), 9.95 (s) .hrms (esi) calcd for c18h34nsn+([m+h]+): 384.1708;Found:384.1712.
2- (to Methyl benzenesulfonyl oxygen methyl) -6- bromopyridine (9): stirring equipped with constant pressure funnel, turned welt plug and magnetic force Mix and in tri- mouthfuls of round-bottomed bottles of 500ml of son, add 2- methylol -6- bromopyridine (11.2g, 59.6mmol) and oxolane (200ml).By system with ice salt bath temperature control to 0 DEG C, the naoh of ice-water bath that disposable addition is prepared in advance cooling (7.20g, Water (50ml) solution 180mmol), dropwise Deca paratoluensulfonyl chloride (12.6g, 66.1mmol) be dissolved in oxolane (50ml) Solution, time for adding be 30 minutes.Drip and finish, be naturally warmed to room temperature, stirring reaction overnight (14 hours), reacted by tlc monitoring Entirely.By system Rotary Evaporators precipitation, residue from dichloromethane (300ml) dilutes, and uses water (200ml) and saturation food successively Saline (200ml) washs, organic faciess anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate is taken off with Rotary Evaporators Molten, obtain faint yellow solid product, be directly completely used for next step reaction.1H nmr (400mhz, cdcl3) δ 7.81 (d, j= 8.3hz, 2h), 7.56 (d, j=8.0hz, 1h), 7.40 (d, j=7.8hz, 2h), 7.34 (d, j=8.1hz, 2h), 5.09 (s, 2h), 2.44 (s, 3h).13C nmr (101mhz, cdcl3) δ 155.18 (s), 145.38 (s), 141.47 (s), 139.36 (s), 132.48 (s), 130.06 (s), 128.12 (s), 127.82 (s), 120.61 (s), 70.73 (s), 21.73 (s) .hrms (esi) calcd for c13h13brno3s+([m+h]+): 341.9794;Found:341.9789.
2- (diethylin methyl) -6- bromopyridine (10): in two mouthfuls of round bottoms of the 250ml equipped with turned welt plug and magnetic stir bar Add 9, diethylamine (43.9g, 600mmol) and oxolane (120ml) in bottle, reaction is stirred at room temperature overnight (14 hours), tlc Monitoring reaction is completely.By system Rotary Evaporators precipitation, residue from dichloromethane (300ml) dilutes, and uses saturated carbon successively Sour hydrogen sodium water solution (200ml), water (200ml) and saturated aqueous common salt (200ml) washing, organic faciess anhydrous sodium sulfate drying, Standing.Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, residue vacuum distillation, collects 56 DEG C/0.1mmhg fraction, Obtain pale yellow oily liquid product 14.0g, two-step reaction yield: 96%.1H nmr (400mhz, cdcl3) δ 7.50 (d, j= 4.9hz, 2h), 7.32 (t, j=4.8hz, 1h), 3.70 (s, 2h), 2.56 (q, j=7.1hz, 4h), 1.03 (t, j=7.1hz, 6h).13C nmr (101mhz, cdcl3) δ 163.09 (s), 141.04 (s), 138.73 (s), 125.85 (s), 121.37 (s), 59.09 (s), 47.51 (s), 12.08 (s) .hrms (esi) calcd for c10h16brn2 +([m+h]+): 243.0491; Found:243.0487.
6- methyl -6 '-(diethylin methyl) -2,2 '-bipyridyl (11): dry equipped with turned welt plug and magnetic stir bar 8 (14.5g, 37.9mmol), 10 (7.71g, 31.7mmol), four (triphenyls are added in dry clean 100ml schlenk bottle Phosphine) palladium (1.28g, 1.11mmol) and anhydrous Lithium chloride (4.10g, 96.7mmol), system is deaerated three times with frozen-thawed, Rearmounted it is changed to argon atmosphere.By system oil bath heating to 120 DEG C, stirring reaction produces a large amount of palladium blacks to system in 16 hours, this When gc show 10 oneself convert completely.System is cooled to room temperature, adds ethyl acetate (100ml) dilution, kieselguhr is filtered to remove not Molten thing, adds 6n hydrochloric acid that system is adjusted to acid (ph=3), point liquid.Aqueous phase 6n sodium hydrate aqueous solution is adjusted to alkaline (ph= 13), extracted with ether (3 × 100ml), organic faciess are washed with saturated aqueous common salt (100ml), anhydrous sodium sulfate drying, standing.Take out Filter desiccant, filtrate uses Rotary Evaporators precipitation, residue vacuum distillation, collects 130 DEG C/0.1mmhg fraction, obtains yellowish Color oily liquids product 6.40g, yield: 79%.1H nmr (400mhz, cdcl3) δ 8.24 (d, j=7.8hz, 1h), 8.19 (d, J=7.8hz, 1h), 7.75 (t, j=7.7hz, 1h), 7.68 (t, j=7.7hz, 1h), 7.48 (d, j=7.6hz, 1h), 7.14 (d, j=7.6hz, 1h), 3.83 (s, 2h), 2.65-2.58 (m, overlap ofq and s, 7h), 1.09 (t, j=7.1hz, 6h).13C nmr (101mhz, cdcl3) δ 160.10 (s), 157.87 (s), 156.07 (s), 155.64 (s), 137.12 (s), 137.05 (s), 123.09 (s), 122.73 (s), 119.15 (s), 118.27 (s), 59.53 (s), 47.51 (s), 24.77 (s), 12.18(s).hrms(esi)calcd for c16h22n3 +([m+h]+): 256.1808;Found:256.1807.
6- (diethylin methyl) -6 '-(di-t-butyl phosphinomethyl) -2,2 '-bipyridyl (1): equipped with turned welt plug and Diisopropylamine (2.38g, 23.5mmol) and anhydrous four are added in the 50ml schlenk bottle of the dried and clean of magnetic stir bar Hydrogen furan (20ml), system is deaerated three times with frozen-thawed, is finally replaced into argon atmosphere.By system with ice salt bath temperature control extremely 0 DEG C, with the hexane solution (2.4m, 9.8ml, 23.5mmol) of syringe dropwise Deca n-BuLi in system, during Deca Between be 15 minutes.Drip and finish, continue to stir 1 hour at 0 DEG C, set aside for use.
In the 100ml schlenk bottle of the dried and clean equipped with turned welt plug and magnetic stir bar add 11 (4.01g, 15.7mmol) with anhydrous tetrahydro furan (10ml), system is deaerated three times with frozen-thawed, is finally replaced into argon atmosphere.Will System ice salt bath temperature control to 0 DEG C, with syringe in system dropwise the oxolane of the above-mentioned lda well prepared in advance of Deca molten Liquid, time for adding is 15 minutes.Drip and finish, continue to stir 2 hours at 0 DEG C.By system liquid nitrogen-acetone cryostat temperature control to -78 DEG C, it is diluted in anhydrous with the syringe di-t-butylchlorophosphine (5.69g, 31.5mmol) that dropwise Deca freeze thawing deaerates in system The solution of oxolane (10ml), time for adding is 30 minutes.Drip and finish, continue in -78 DEG C of stirring reactions 30 minutes, clear-cutting forestland Reaction is stirred at room temperature overnight (14 hours).Ether (30ml) and the water (30ml) of freeze thawing degassing is added after system vacuum desolvation, point Liquid, ether extraction (2 × 10ml) that aqueous phase freeze thawing deaerates, merge organic faciess, under argon protection, use anhydrous sodium sulfate drying, quiet Put.It is filtered to remove desiccant, filter vacuum precipitation, residue vacuum distillation, collect 180 DEG C/0.1mmhg fraction, obtain faint yellow Viscous oil-like liquid, standing gradually solidifies, and obtains faint yellow solid product 3.30g, yield: 53%.1H nmr (400mhz, cdcl3) δ 8.26 (d, j=7.7hz, 1h), 8.18 (d, j=7.7hz, 1h), 7.74 (t, j=7.7hz, 1h), 7.68 (t, j=7.7hz, 1h), 7.46 (d, j=7.7hz, 1h), 7.40 (d, j=7.7hz, 1h), 3.82 (s, 2h), 3.14 (d, j=2.4hz, 2h), 2.62 (q, j=7.0hz, 4h), 1.18 (d, j=11.0hz, 18h), 1.09 (t, j=7.0hz, 6h).13C nmr (101mhz, cdcl3) δ 161.46 (d, j=13.7hz), 159.88 (s), 155.70 (s), 155.49 (s), 137.16 (s), 137.00 (s), 123.82 (d, j=8.5hz), 122.75 (s), 119.14 (s), 117.99 (s), 59.46 (s), 47.53 (s), 32.09 (d, j =21.6hz), 31.97 (d, j=23.9hz), 29.86 (d, j=13.2hz), 12.18 (s).31P nmr (162mhz, cdcl3) δ37.12(s).hrms(esi)calcd for c24h39n3p+([m+h]+): 400.2876;Found:400.2867.
Embodiment 2
The preparation of part 2
2- [(t-Butyldimethylsilyl) methyl] -6- bromopyridine (12): dry equipped with turned welt plug and magnetic stir bar Add in dry clean 100ml schlenk bottle 2- methylol -6- bromopyridine (10.6g, 56.4mmol) and imidazoles (15.4g, 226mmol), system is replaced into argon atmosphere, adds anhydrous dmf (50ml), the disposable addition tert-butyl group in argon stream Dimethylchlorosilane (10.2g, 67.7mmol).Finish, reaction 1 hour is stirred at room temperature, tlc monitoring reaction completely, adds water (50ml) reaction is quenched, with ether (3 × 100ml) extraction product, organic faciess priority water (100ml) and saturated aqueous common salt (100ml) wash, anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, and residue subtracts Pressure distillation, collects 92 DEG C/0.1mmhg fraction, obtains colourless oil liquid product 15.3g, yield: 90%.1H nmr (400mhz, cdcl3) δ 7.56 (t, j=7.7hz, 1h), 7.47 (dd, j=7.6,0.8hz, 1h), 7.33 (dd, j=7.8,0.7hz, 1h), 4.80 (s, 2h), 0.95 (s, 9h), 0.11 (s, 6h).
2- [(t-Butyldimethylsilyl) methyl] -6- (tri-n-butyl tin base) pyridine (13): equipped with turned welt plug and magnetic Add 12 (15.5g, 51.3mmol) in tetra- mouthfuls of round-bottomed bottles of the 250ml of the dried and clean of power stirrer, system is replaced into argon Atmosphere, adds anhydrous thf (150ml), by system liquid nitrogen-acetone cryostat temperature control to -78 DEG C, with syringe in system dropwise The hexane solution (2.4m, 25ml, 60.0mmol) of Deca n-BuLi, time for adding is 30 minutes.Drip and finish, continue -78 DEG C stirring reaction 1 hour.It is diluted in anhydrous thf with syringe to Deca tributyltin chloride (20.0g, 61.4mmol) in system (30ml) solution, time for adding is 30 minutes.Drip and finish, after continuing to stir 30 minutes at -78 DEG C, clear-cutting forestland is stirred at room temperature instead Should overnight (14 hours).System Rotary Evaporators precipitation, residue with diethyl ether (200ml) dilute, successively use water (200ml) and Saturated aqueous common salt (200ml) washs, organic faciess anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate is steamed with rotation Send out instrument precipitation, residue vacuum distillation, collect 170 DEG C/0.1mmhg fraction, obtain colourless oil liquid product 23.0g, yield: 87%.1H nmr (400mhz, cdcl3) δ 7.49 (t, j=7.6hz, 1h), 7.31 (d, j=7.4hz, 1h), 7.24 (d, j= 7.8hz, 1h), 4.83 (s, 2h), 1.60-1.49 (m, 6h), 1.36-1.28 (m, 6h), 1.12-1.05 (m, 6h), 0.95 (s, 9h), 0.87 (t, j=7.3hz, 9h), 0.12 (s, 6h).13C nmr (101mhz, cdcl3) δ 172.63 (s), 161.56 (s), 133.78 (s), 130.57 (s), 118.49 (s), 66.77 (s), 29.22 (s), 27.46 (s), 26.10 (s), 18.52 (s), 13.84 (s), 9.98 (s), -5.16 (s) .hrms (esi) calcd for c24h48nosisn+([m+h]+): 514.2522; Found:514.2530.
6- methylol -6 '-(diethylin methyl) -2,2 '-bipyridyl (14): equipped with turned welt plug and magnetic stir bar 10 (8.51g, 35.0mmol), 13 (21.5g, 42.0mmol), four (triphens are added in the 100ml schlenk bottle of dried and clean Base phosphine) palladium (1.42g, 1.23mmol) and anhydrous Lithium chloride (4.49g, 106mmol), system is deaerated three times with frozen-thawed, Finally it is replaced into argon atmosphere.By system oil bath heating to 120 DEG C, stirring reaction produces a large amount of palladium blacks to system in 10 hours, Now gc shows that 10 convert completely.System is cooled to room temperature, adds ethyl acetate (100ml) dilution, kieselguhr is filtered to remove Insoluble matter, adds 6n hydrochloric acid that system is adjusted to acid (ph=3), point liquid.Aqueous phase 6n sodium hydrate aqueous solution is adjusted to alkaline (ph =13), extracted with ether (3 × 100ml), organic faciess are washed with saturated aqueous common salt (100ml), anhydrous sodium sulfate drying, standing. Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, residue vacuum distillation, collects 150 DEG C/0.1mmhg fraction, obtains light Yellow oily liquid product 8.00g, yield: 84%.1H nmr (400mhz, cdcl3) δ 8.36 (d, j=7.8hz, 1h), 8.26 (d, j=7.8hz, 1h), 7.81,7.79 (2t, partially overlapped, j=7.8hz, 2h), 7.52 (d, j= 7.8hz, 1h), 7.22 (d, j=7.7hz, 1h), 4.83 (s, 2h), 4.06 (s, 1h), 3.84 (s, 2h), 2.63 (q, j= 7.1hz, 4h), 1.10 (t, j=7.1hz, 6h).13C nmr (101mhz, cdcl3) δ 160.26 (s), 158.22 (s), 155.30 (s), 154.76 (s), 137.67 (s), 137.23 (s), 123.19 (s), 120.29 (s), 119.89 (s), 119.06 (s), 64.05 (s), 59.46 (s), 47.53 (s), 12.16 (s) .hrms (esi) calcd for c16h22n3o+([m+h]+): 272.1757;Found:272.1762.
Chloro- 6 '-(the diethylin methyl) -2 of 6-, 2 '-bipyridyl (15): in the drying equipped with turned welt plug and magnetic stir bar Add 14 (5.81g, 21.4mmol) in clean two mouthfuls of round-bottomed bottles of 250ml, system is replaced into argon atmosphere, add anhydrous two Chloromethanes (80ml), by 0 DEG C of ice salt bath temperature control of system, with syringe in system dropwise Deca thionyl chloride (13.0g, 109mmol) it is diluted in the solution of dichloromethane (20ml), time for adding is 30 minutes.Drip and finish, remove cryostat, use oil bath heating To 45 DEG C of stirring reactions 3 hours, tlc monitoring reaction completely, system was cooled to and pours the beaker filling ice cube (100g) after room temperature into In, be adjusted to alkaline (ph=13) with 6n naoh aqueous solution, with dichloromethane (3 × 50ml) extraction, use successively water (100ml) and Saturated aqueous common salt (100ml) washs, organic faciess anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate is steamed with rotation Send out instrument precipitation, obtain pale brown oil product liquid, this compound is unstable, be all directly used in next step reaction.1h nmr (400mhz, cdcl3) δ 8.36 (d, j=7.9hz, 1h), 8.28 (d, j=7.7hz, 1h), 7.83 (t, j=7.7hz, 1h), 7.77 (t, j=7.7hz, 1h), 7.50,7.48 (2d, partially overlapped, j=8.8hz and8.4hz, 2h), 4.75 (s, 2h), 3.83 (s, 2h), 2.62 (q, j=7.0hz, 4h), 1.09 (t, j=7.1hz, 6h).13C nmr (101mhz, cdcl3) δ 160.19 (s), 156.25 (s), 156.07 (s), 154.86 (s), 137.93 (s), 137.25 (s), 123.20 (s), 122.56 (s), 120.49 (s), 119.33 (s), 59.47 (s), 47.54 (s), 47.13 (s), 12.18 (s) .hrms (esi) calcd for c16h21cln3 +([m+h]+): 290.1419;Found:290.1427.
6- (diethylin methyl) -6 '-(diphenylphosphinomethyl) -2,2 '-bipyridyl (2): equipped with turned welt plug and magnetic Add potassium tert-butoxide (3.40g, 30.3mmol) in the 250ml schlenk bottle of the dried and clean of power stirrer, system is replaced For argon atmosphere, add the anhydrous tetrahydro furan (50ml) of freeze thawing degassing, by system with ice salt bath temperature control to 0 DEG C.Use syringe To in system, the diphenylphosphine (4.69g, 25.2mmol) of dropwise Deca freeze thawing degassing is diluted in anhydrous tetrahydro furan (15ml) Solution, time for adding is 15 minutes.Drip and finish, continue to keep 0 DEG C of stirring reaction 1 hour, obtain a peony settled solution.With injection 15 solution being dissolved in anhydrous tetrahydro furan (15ml) of device dropwise Deca freeze thawing degassing in system, time for adding is 30 minutes. Drip and finish, continue to keep 0 DEG C of stirring reaction 30 minutes, clear-cutting forestland is stirred at room temperature reaction overnight (14 hours).With syringe to body The distilled water (30ml) of freeze thawing degassing, point liquid is added, aqueous phase with ether (2 × 10ml) extraction of freeze thawing degassing, merges again in system Organic faciess, use anhydrous sodium sulfate drying, standing under argon protection.It is filtered to remove desiccant, filter vacuum precipitation, residue subtracts Pressure distillation, collects 230 DEG C/0.1mmhg fraction, obtains pale yellow oily liquid product 5.00g, two-step reaction yield: 54%.1h Nmr (400mhz, cdcl3) δ 8.18 (d, j=7.8hz, 1h), 8.02 (d, j=7.7hz, 1h), 7.69 (t, j=7.7hz, 1h), 7.60 (t, j=7.7hz, 1h), 7.53-7.47 (m, 4h), 7.45 (d, j=7.7hz, 1h), 7.37-7.28 (m, 6h), 7.02 (d, j=7.6hz, 1h), 3.81 (s, 2h), 3.71 (s, 2h), 2.62 (q, j=7.1hz, 4h), 1.09 (t, j= 7.1hz, 6h).13C nmr (101mhz, cdcl3) δ 159.93 (s), 157.46 (d, j=7.5hz), 156.02 (s), 155.49 (s), 138.59 (d, j=14.9hz), 137.06 (s, 2c, one carbon missing due to overlap), 133.15 (d, j=19.0hz), 128.74 (s), 128.47 (d, j=6.8hz), 123.47 (d, j=5.5hz), 122.81 (s), 119.42 (s), 118.45 (d, j=1.4hz), 59.53 (s), and 47.55 (s), 38.72 (d, j=16.3hz), 12.23 (s).31p Nmr (162mhz, cdcl3)δ-11.09(s).hrms(esi)calcd for c28h31n3p+([m+h]+): 440.2250; Found:440.2258.
Embodiment 3
The preparation of part 3
6,6 '-dihydroxymethyl -2,2 '-bipyridyl (16): in the dried and clean equipped with turned welt plug and magnetic stir bar 12 (8.49g, 28.1mmol), 13 (16.9g, 33.0mmol), tetrakis triphenylphosphine palladium is added in 100mlschlenk bottle (1.14g, 0.99mmol) and anhydrous Lithium chloride (3.60g, 84.9mmol), system is deaerated three times with frozen-thawed, the most rearmounted It is changed to argon atmosphere.By system oil bath heating to 120 DEG C, stirring reaction produces a large amount of palladium blacks, now gc to system in 12 hours Display 12 converts completely.System is cooled to room temperature, adds ethyl acetate (100ml) dilution, kieselguhr is filtered to remove insoluble matter, Add 6n hydrochloric acid that system is adjusted to acid (ph=3), point liquid.Aqueous phase 6n sodium hydrate aqueous solution is adjusted to alkaline (ph=13), Extracted with ether (3 × 100ml), organic faciess are washed with saturated aqueous common salt (100ml), anhydrous sodium sulfate drying, standing.Sucking filtration removes Remove desiccant, filtrate uses Rotary Evaporators precipitation, obtain white solid product 5.20g, yield: 85%.1H nmr (400mhz, Dmso) δ 8.23 (d, j=7.7hz, 2h), 7.93 (t, j=7.8hz, 2h), 7.52 (d, j=7.6hz, 2h), 5.48 (t, j= 5.8hz, 2h), 4.65 (d, j=5.7hz, 4h).
6,6 '-dichloromethyl -2,2 '-bipyridyl (17): in the dried and clean equipped with turned welt plug and magnetic stir bar Add 16 (1.71g, 7.91mmol) in 100ml schlenk bottle, system is replaced into argon atmosphere, add anhydrous methylene chloride (40ml), by 0 DEG C of ice salt bath temperature control of system, with syringe in system dropwise Deca thionyl chloride (4.81g, 40.4mmol) It is diluted in the solution of dichloromethane (10ml), time for adding is 15 minutes.Drip and finish, remove cryostat, stirred to 45 DEG C with oil bath heating Mix reaction 3 hours, tlc monitoring reaction completely, system is cooled to and pours into after room temperature in the beaker filling ice cube (100g), use 6n Naoh aqueous solution is adjusted to alkaline (ph=13), with dichloromethane (3 × 50ml) extraction, organic phase washed with water (100ml) and satisfying With saline solution (100ml) washing, anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, Obtain faint yellow solid product 1.80g, yield: 90%.1H nmr (400mhz, cdcl3) δ 8.40 (d, j=7.9hz, 2h), 7.85 (t, j=7.8hz, 2h), 7.51 (d, j=7.7hz, 2h), 4.75 (s, 4h).
6,6 '-bis- (di-t-butyl phosphinomethyl) -2,2 '-bipyridyl (3): dry equipped with turned welt plug and magnetic stir bar Add 17 (1.01g, 3.99mmol) in dry clean 50ml schlenk bottle, system is replaced into argon atmosphere, add freeze thawing The di-t-butyl phosphine (2.34g, 16.0mmol) of degassing is diluted in the solution of absolute methanol (30ml), is heated to system with oil bath 60 DEG C of stirring reactions 48 hours, obtain a white suspension.System is cooled to room temperature, adds freeze thawing to deaerate in system with syringe Triethylamine (2.10g, 20.8mmol), mixture continues to be stirred at room temperature reaction overnight (14 hours).By system vacuum desolvation, Residue adds the dichloromethane (50ml) of freeze thawing degassing, is washed with the distilled water (3 × 10ml) of freeze thawing degassing, organic faciess are in argon Anhydrous sodium sulfate drying is used, standing under gas shielded.Filtered with short neutral aluminium sesquioxide post, filter vacuum precipitation, obtain white Solid product 1.30g, yield: 69%.1H nmr (400mhz, cdcl3) δ 8.17 (d, j=7.7hz, 2h), 7.67 (t, j= 7.7hz, 2h), 7.39 (d, j=7.7hz, 2h), 3.13 (d, j=3.2hz, 4h), 1.18 (d, j=11.0hz, 36h).13c Nmr (101mhz, cdcl3) δ 161.33 (d, j=13.8hz), 155.49 (s), 136.91 (s), 123.67 (d, j=8.4hz), 117.87 (s), 32.03 (d, j=21.7hz), 31.91 (d, j=23.9hz), 29.81 (d, j=13.2hz).31p nmr (162mhz, cdcl3)δ37.02(s).hrms(esi)calcd for c28h47n2p2 +([m+h]+): 473.3209;Found: 473.3213.
Embodiment 4
The preparation of part 4
Two mouthfuls of round-bottomed bottles of 100ml of dried and clean equipped with reflux condensing tube, turned welt plug and magnetic stir bar add 17 (1.50g, 5.93mmol), diethylamine (4.30g, 58.8mmol) and oxolane (50ml), by system with oil bath heating extremely 70 DEG C of stirring reactions 4 hours, tlc monitoring reaction is completely.System is cooled to room temperature, uses Rotary Evaporators precipitation, residue uses two Chloromethanes (50ml) dilute, and are washed with saturated sodium bicarbonate aqueous solution (50ml), water (50ml) and saturated aqueous common salt (50ml) successively Wash, organic faciess anhydrous sodium sulfate drying, standing.Sucking filtration removes desiccant, and filtrate uses Rotary Evaporators precipitation, and residue reduces pressure Distillation, collects 120 DEG C/0.1mmhg fraction, obtains pale yellow oily liquid product 1.50g, yield: 78%.1H nmr (400mhz, cdcl3) δ=8.25 (d, j=7.7,2h), 7.76 (t, j=7.7,2h), 7.48 (d, j=7.6,2h), 3.83 (s, 4h), 2.62 (q, j=7.1,8h), 1.09 (t, j=7.1,12h).13C nmr (101mhz, cdcl3) δ=160.06 (s), 155.69 (s), 137.18 (s), 122.78 (s), 119.23 (s), 59.52 (s), 47.53 (s), 12.21 (s) .hrms (esi) calcd for c20h31n4 +([m+h]+): 327.2543;Found:327.2550.
Embodiment 5
The preparation of complex 5
In the 15ml schlenk pipe of the dried and clean equipped with turned welt plug and magnetic stir bar add 1 (600mg, 1.50mmol) with [rucl26-p-cymene)]2(400mg, 0.65mmol), system is replaced into argon atmosphere, adds freeze thawing The anhydrous methylene chloride (5ml) of degassing.Stirring reaction 4 hours under room temperature, obtain a dark purple black suspension, directly use rotary evaporation Instrument precipitation, residue with diethyl ether (3 × 10ml) washs, sucking filtration, vacuum drying, obtains dark purple black solid powder 740mg, yield: 99%.1H nmr (400mhz, cdcl3) δ 7.93 (d, j=8.0hz, 1h), 7.80-7.71 (m, 2h), 7.48 (d, j=7.6hz, 1h), 7.45-7.33 (m, 2h), 4.45 (s, 2h), 3.62 (d, j=8.5hz, 2h), 3.57,3.54 (2q, partially Overlapped, j=6.8hz and6.7hz, 2h), 3.25,3.22 (2q, partially overlapped, j=6.6hz And6.6hz, 2h), 1.44 (d, j=11.8hz, 18h), 1.18 (t, j=7.0hz, 6h).13C nmr (101mhz, cdcl3)δ 169.25 (d, j=3.3hz), 161.58 (d, j=2.0hz), 161.00 (s), 158.56 (s), 134.17 (s), 131.69 (s), 121.16 (d, j=1.9hz), 120.56 (s), 120.47 (s), 120.30 (s), 67.79 (s), 51.42 (s), 38.67 (d, j=14.5hz), 38.31 (d, j=7.1hz), 30.78 (d, j=3.9hz), 10.71 (s).31P nmr (162mhz, cdcl3)δ63.21(s).anal.calcd.for c24h38cl2n3Pru:c, 50.44;H, 6.70;N, 7.35.found:c, 50.34;H, 6.92;N, 7.31.
Embodiment 6
The preparation of complex 6
In the 15ml schlenk pipe of the dried and clean equipped with turned welt plug and magnetic stir bar add 2 (210mg, 0.48mmol) with [rucl26-p-cymene)]2(122mg, 0.20mmol), system is replaced into argon atmosphere, adds freeze thawing The dry toluene (5ml) of degassing.System oil bath heating, to 120 DEG C of stirring reactions 16 hours, obtains a dark purple black suspension, very Empty precipitation, residue with diethyl ether (3 × 5ml) and ethanol (3 × 5ml) washing, sucking filtration, vacuum drying, obtain dark purple black solid powder Last 210mg, yield: 86%.1H nmr (400mhz, cdcl3) δ 8.00 (d, j=8.3hz, 1h), 7.88-7.81 (m, 2h), 7.80-7.70 (m, 4h), 7.57-7.47 (m, 3h), 7.41-7.31 (m, 6h), 4.54 (s, 2h), 4.27 (d, j=10.2hz, 2h), 3.38,3.35 (2q, partially overlapped, j=6.8hz and6.7hz, 2h), 3.20,3.17 (2q, Partially overlapped, j=6.4hz and6.6hz, 2h), 1.08 (t, j=7.0hz, 6h).13C nmr (101mhz, cdcl3) δ 165.93 (d, j=5.1hz), 160.76 (d, j=3.1hz), 160.53 (s), 157.62 (s), 137.24 (d, j= 34.5hz), 134.74 (s), 133.61 (d, j=10.4hz), 132.12 (s), and 129.27 (s), 127.82 (d, j=8.9hz), 121.45 (d, j=2.9hz), 120.82 (s), 120.69 (s), 120.56 (d, j=9.3hz), 66.63 (s), 51.28 (s), (48.59 d, j=25.4hz), 10.53 (s).31P nmr (162mhz, cdcl3)δ45.75(s).hrms(esi)calcd for c28h30cln3pru+([m-cl]+): 576.0904;Found:576.0897.
Embodiment 7
The preparation of complex 7
In the 15ml schlenk pipe of the dried and clean equipped with turned welt plug and magnetic stir bar add 3 (113mg, 0.24mmol) with [rucl26-p-cymene)]2(61mg, 0.10mmol), system is replaced into argon atmosphere, adds freeze thawing The anhydrous methylene chloride (5ml) of degassing.Stirring reaction 4 hours under room temperature, obtain a dark purple black suspension, directly use rotary evaporation Instrument precipitation, residue with diethyl ether (3 × 5ml) washs, sucking filtration, vacuum drying, obtains dark purple black solid powder 117mg, yield: 91%.1H nmr (400mhz, cdcl3) δ 7.87 (d, j=7.8hz, 2h), 7.63 (t, j=7.8hz, 2h), 7.57 (d, j= 7.7hz, 2h), 3.87 (d, j=8.3hz, 4h), 1.45 (d, j=11.3hz, 36h).13C nmr (101mhz, cdcl3)δ 166.50 (s), 159.51 (s), 134.04 (s), 122.30 (vt, j=4.8hz), 120.45 (s), 39.25 (dd, j=11.8, 6.7hz), 37.46 (vt, j=3.8hz), 30.70 (s).31P nmr (162mhz, cdcl3)δ66.25(s) .anal.calcd.for c28h46cl2n2p2Ru:c, 52.17;H, 7.19;N, 4.35.found:c, 52.29;H, 6.91;N, 4.56.
Embodiment 8
The operation of elaboration ester type compound catalytic hydrogenation taking gamma-valerolactone as a example:
A) use generated in-situ bipyridyl tetradentate ligandses ruthenium complex solution
Ligand 1 (1.4mg, 3.6 μm of ol) and [rucl is weighed in glove box26-p-cymene)]2(0.9mg, 1.5 μ Mol) in the 10ml schlenk pipe equipped with turned welt plug and magnetic stir bar, add the oxolane (2.0ml) of freeze thawing degassing, Under 25 DEG C and the protection of argon ball, stirring reaction 30 minutes, obtains the tetrahydrofuran solution of bipyridyl tetradentate ligandses ruthenium complex 5.Claim Take Feldalat NM (17mg, 0.3mmol) in the glass reaction inner tube equipped with magnetic stir bar, be put in rapidly in autoclave, displacement For argon atmosphere.With syringe by the tetrahydrofuran solution of above-mentioned bipyridyl tetradentate ligandses ruthenium complex 5 and freeze thawing degassing pre- Oxolane (3.0ml) solution of the gamma-valerolactone (300mg, 3.0mmol) first prepared is added in high-pressure hydrogenation kettle, uses hydrogen Gas replaces the gas five times in autoclave, and finally adjusting Hydrogen Vapor Pressure is 5mpa, and 25 DEG C of stirring reactions 6 hours are to pressure gauge no longer Change, slowly releases the hydrogen in autoclave, adds 1,5-PD as internal standard, takes a small amount of sample to filter through short silicagel column The yield using gas Chromatographic Determination Isosorbide-5-Nitrae-pentanediol afterwards is 96%.
Using part 2 and [rucl26-p-cymene)]2Generated in-situ bipyridyl tetradentate ligandses ruthenium complex solution is urged After changing hydrogenation gamma-valerolactone reaction 14 hours, Isosorbide-5-Nitrae-pentanediol yield is 67%;Using part 3 and [rucl26-p- cymene)]2After generated in-situ bipyridyl tetradentate ligandses ruthenium complex solution catalyzing hydrogenation gamma-valerolactone reacts 14 hours, 1, 4- pentanediol yield is 25%;Using part 4 and [rucl26-p-cymene)]2Generated in-situ bipyridyl tetradentate ligandses ruthenium After complex solution catalytic hydrogenation gamma-valerolactone reacts 14 hours, Isosorbide-5-Nitrae-pentanediol yield is 15%.
Analytical conditions for gas chromatography is: agilent db-35 chromatographic column (30m × 0.32mm × 0.25 μm), fid detection Device, injector temperature is 230 DEG C, and detector temperature is 250 DEG C, and carrier gas is nitrogen, and constant flow rate is 1.0ml/min.Program liter Temperature: initial temperature is 50 DEG C, rises to 250 DEG C with the heating rate of 10 DEG C/min, keeps 10 minutes at such a temperature.Isosorbide-5-Nitrae-penta two Alcohol, gamma-valerolactone, the retention time of 1,5-PD are respectively 7.92min, 8.30min, 9.04min.
B) use synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex
Glove box weighs bipyridyl tetradentate ligandses ruthenium complex 5 (1.7mg, 3.0 μm of ol) and Feldalat NM (17mg, 0.3mmol) in the glass reaction inner tube equipped with magnetic stir bar, it is added thereto to the preparation in advance of freeze thawing degassing with syringe Gamma-valerolactone (300mg, 3.0mmol) oxolane (5.0ml) solution, stir, be put in rapidly in autoclave, put It is changed to argon atmosphere.With the gas in hydrogen exchange autoclave five times, finally adjusting Hydrogen Vapor Pressure is 5mpa, 25 DEG C of stirring reactions No longer change to pressure gauge within 4 hours, slowly release the hydrogen in autoclave, add 1,5-PD as internal standard, take a small amount of The yield of gas Chromatographic Determination Isosorbide-5-Nitrae-pentanediol used through short silicagel column by sample after filtering be 98%.
Anti- for catalyst hydrogenation gamma-valerolactone using synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex 6 After answering 7 hours, Isosorbide-5-Nitrae-pentanediol yield is 96%;The use of synthetically prepared solid bipyridyl tetradentate ligandses ruthenium complex 7 is to urge After agent catalytic hydrogenation gamma-valerolactone reacts 14 hours, Isosorbide-5-Nitrae-pentanediol yield is 30%.
Embodiment 9
Optimized using synthetically prepared bipyridyl tetradentate ligandses ruthenium complex 5 for substrate with gamma-valerolactone and compare catalysis hydrogen Change the experiment condition of reaction, the reaction result of the experiment condition such as different catalysts, solvent, alkali and Hydrogen Vapor Pressure is shown in Table 1.
The comparison of table 1 gamma-valerolactone hydrogenation experiment conditiona
aReaction condition: s/c=1000,3.0mmol gamma-valerolactone, 3.0 μm of ol5,5.0mllProh, 25 DEG C.bComposed by gas Measure, be separation yield in bracket, in all reactions, all only observe that Isosorbide-5-Nitrae-pentanediol and unreacted gamma-valerolactone are deposited ?.cS/c=10,000,12mmol gamma-valerolactone, 1.2 μm of ol5,1.0mllProh, 1.2mmol naome.dS/c=100, 000,36mmol gamma-valerolactone, 0.36 μm of ol5,4.0mllProh, 3.6mmol naome.e40℃.
Embodiment 10
Hydrogenation using synthetically prepared bipyridyl tetradentate ligandses ruthenium complex 5 catalytic hydrogenation other ester type compound The results are shown in Table 2:
The hydrogenation of the other ester type compound of table 2a
aReaction condition: s/c=1000,3.0mmol substrate, 3.0 μm of ol5,3.0mllProh, 0.3mmol naome, 5mpa h2, 25 DEG C.bGas composes yield, is separation yield in bracket, all only observes target product and unreacted former in all reactions Material exists.cSurplus materialss are gamma-valerolactone.d100℃.eS/c=333,100 DEG C, 1.0mmol substrate.fOxolane is molten Agent.gS/c=10,000,12mmol substrate, 1.2 μm of ol5,1.2mmol naome.hS/c=100,000,100mmol benzoic acid Methyl ester, 1.0 μm of ol5,20mllProh, 10.0mmol naome.l40℃.j10mpa h2.kS/c=100,000,200mmol second Acetoacetic ester, 2.0 μm of ol5,20.0mmol naoet.
The preparation of bipyridyl tetradentate ligandses ruthenium complex is demonstrated conveniently by above-described embodiment, good stability, and in ester Excellent catalysis activity is shown, catalyst amount is little, reaction condition is gentle, the selectivity of reaction in class chemical combination hydrogenation Good, show very high industrial application value.

Claims (10)

1. a kind of bipyridyl tetradentate ligandses are it is characterised in that it has a structural formula as shown in i:
Wherein, coordinating group l1And l2Independently selected from: pr1r2、nr1r2, but it is not simultaneously selected from pr1r2、nr1r2
r1And r2Independently selected from: c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthyl, heteroaryl Base, benzyl;Substituent group on described substituted phenyl is c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, alkoxyl and halogen Element, substituent group quantity is 1~5;Described heteroaryl is furyl, thienyl or pyridine radicals;r1、r2Identical or different;Or r1、 r2And be c3~c8Cycloaliphatic ring or aromatic rings;
x1、x2Independently selected from: h, c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthyl, miscellaneous Aryl, benzyl, halogen;Substituent group on described substituted phenyl is c1~c8Alkyl, c3~c8Cycloalkyl, phenyl, alkoxyl And halogen, substituent group quantity is 1~5;Described heteroaryl is furyl, thienyl or pyridine radicals;M=0~3, n=0~ 3;When m >=2, two adjacent x1Can and be c3~c8Cycloaliphatic ring or aromatic rings;When n >=2, two adjacent x2Can and be c3 ~c8Cycloaliphatic ring or aromatic rings;x1、x2Identical or different.
2. according to the bipyridyl tetradentate ligandses described in claim 1 it is characterised in that described c1~c8Alkyl be methyl, ethyl, N-pro-pyl, isopropyl, normal-butyl, the tert-butyl group;Described c3~c8Cycloalkyl is cyclopropyl, cyclobutyl, cyclopenta, cyclohexyl;Institute The alkoxyl stated is methoxyl group, ethyoxyl, positive propoxy, isopropoxy, n-butoxy, tert-butoxy.
3. according to the bipyridyl tetradentate ligandses described in claim 1 it is characterised in that described bipyridyl tetradentate ligandses are structure Shown in formula 1,2:
4. a kind of bipyridyl tetradentate ligandses ruthenium complex by the bipyridyl tetradentate ligandses preparation described in claim 1, its feature It is that it has a structural formula as shown in ii:
Wherein, l1、l2、x1、x2, m, n definition identical with described in formula i;Y, z are h, cl, br, i, clo4、pf6、bph4、b (c6f5)4、bf4、bh4、ocor、ococf3、oso2r、oso2cf3、cn、or、nr2、sr;R is h, c1~c8Alkyl, c3~c8Cycloalkanes Base, phenyl, the phenyl replacing, 1- naphthyl, 2- naphthyl, heteroaryl, benzyl;Substituent group on described substituted phenyl is c1~ c8Alkyl, c3~c8Cycloalkyl, phenyl, alkoxyl and halogen, substituent group quantity is 1~5;Described heteroaryl be furyl, Thienyl or pyridine radicals;Y, z are identical or different.
5. it is characterised in that described y, z is identical halogen to bipyridyl tetradentate ligandses ruthenium complex according to claim 4 Element: cl, br, i.
6. bipyridyl tetradentate ligandses ruthenium complex according to claim 4 is it is characterised in that described bipyridyl four tooth is joined Body ruthenium complex is shown in structural formula 5,6:
7. the preparation method of the bipyridyl tetradentate ligandses ruthenium complex described in claim 4 is it is characterised in that include following method:
1) in-situ preparation: in dichloromethane, oxolane, toluene, n, in n- dimethylformamide or dimethyl sulfoxide organic solvent, Metal ruthenium precursor and the described bipyridyl tetradentate ligandses of amount 1.0~1.5 times amount with respect to ruthenium atom material, at 25~120 DEG C Reaction 4~16 hours, you can obtain bipyridyl tetradentate ligandses ruthenium complex solution;
Or
2) synthetically prepared: in dichloromethane, oxolane, toluene, n, n- dimethylformamide, dimethyl sulfoxide organic solvent, Metal ruthenium precursor and the described bipyridyl tetradentate ligandses of amount 1.0~1.5 times amount with respect to ruthenium atom material, at 25~120 DEG C Reaction 4~16 hours, solution rotating is evaporated to original volume 1/10;The solution of concentration is added ether or normal hexane under agitation, Separate out dark purple black solid, vacuum filtration, wash filter cake with ether or normal hexane, after filter cake vacuum drying, obtain solid bipyridyl Tetradentate ligandses ruthenium complex;
Described metal ruthenium precursor is rucl3·nh2o、[rucl2(co)3]2、[ru(cod)cl2]n、[ru(nbd)cl2]n、 [rucl2ph]2、[rubr2ph]2、[rui2ph]2、[rucl2(p -Methylisopropylbenzene)]2、[rubr2(to isopropyl methyl Benzene)]2、[rui2(p -Methylisopropylbenzene)]2、[rucl2(1,3,5-trimethyl-benzene)]2、[rubr2(1,3,5-trimethyl-benzene) ]2、[rui2(1,3,5-trimethyl-benzene)]2、rucl2(pph3)3、rubr2(pph3)3、rui2(pph3)3、rucl2(dmso)4, its In, cod=1,5- cyclo-octadiene, nbd=2,5- norbornadiene, dmso=dimethyl sulfoxide.
8. the application of the bipyridyl tetradentate ligandses ruthenium complex described in claim 4 is it is characterised in that it is used for as catalyst Ester type compound catalytic hydrogenation synthesizes in the reaction of alcohol compound, and described ester type compound is as shown in formula iii:
Wherein, ra、rbSelected from c1~c30Alkyl, c3~c30Cycloalkyl, c2~c30Thiazolinyl, c3~c30Cycloalkenyl group, aryl, these bases The substituent group arbitrarily not affecting hydrogenation, r is contained in groupa、rbIdentical or different;Or ra、rbIt is connected and form the c of ring-type4~ c30Lactone, lactonic ring contains arbitrarily does not affect the substituent group of hydrogenation, and on lactonic ring, the carbon atom of correct position can quilt O, n, s hetero atom replaces, and lactonic ring is monocyclic or multi-ring;Described lactone is saturation lactone or unsaturated lactone;
Described alcohol compound is as shown in formula iv-a, iv-b:
ra、rbDefinition identical with described in formula iii;Work as ra、rbAlcohol compound such as iv-a, iv-b institute described in when not being connected Show;Work as ra、rbAlcohol compound described in when connected is the dihydroxylic alcohols of gained after corresponding lactone reduction;When hydrogenation esters used When containing multiple ester group in compound, the alcohol compound of gained is corresponding polyhydric alcohol.
9. the application of bipyridyl tetradentate ligandses ruthenium complex according to claim 8 is it is characterised in that described esters Compound is: essence of Niobe, ethyl acetate, ethylene carbonate, methyl ester levulinate, dimethyl succinate, gamma-butyrolacton, Gamma-valerolactone, Alpha-Methyl-gamma-butyrolacton, methyl glycollate, methyl lactate, methoxy menthyl acetate, methyl laurate, Hard Fat Sour methyl ester, trilaurin, glyceryl tristearate, dimethyl oxalate., 1,2- phthalic acid methyl ester, 1,3- phthalic acid Methyl ester, methyl caproate, hexyl hexanoate.
10. the application of bipyridyl tetradentate ligandses ruthenium complex according to claim 8 is it is characterised in that to ester type compound Catalytic hydrogenation application method comprise the steps:
Under argon or nitrogen are protected, by catalyst be bipyridyl tetradentate ligandses ruthenium complex and alkali adds in reactor inner tube, Add substrate to be dissolved in the solution of coordinative solvent, tighten reactor and with the careful displacement of hydrogen 3~5 times, adjust Hydrogen Vapor Pressure to institute After needing pressure, stirring reaction no longer changes to pressure at appropriate temperatures, and reactor is recovered room temperature, slowly discharges residual hydrogen Gas;Product carries out separating-purifying by column chromatography, the conventional organic compound purification process of distillation;
Catalyst amount be substrate materials amount 0.001~0.3mol%, alkali consumption be substrate materials amount 1~ 10mol%, Hydrogen Vapor Pressure 1~10mpa, reaction temperature is 25~100 DEG C, and the response time is 2~64 hours;
Solvent for use is one of oxolane, ether, 2- methyltetrahydrofuran, isopropanol, toluene organic solvent or wherein Several mixed solvents;Alkali used is Feldalat NM, Sodium ethylate, sodium isopropylate, sodium tert-butoxide, Feldalat KM, potassium ethoxide, isopropanol Potassium, potassium tert-butoxide;The consumption of alkali is 1~10mol% of the amount of ester type compound material.
CN201410242328.4A 2014-05-28 2014-05-28 Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof Active CN103980317B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410242328.4A CN103980317B (en) 2014-05-28 2014-05-28 Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410242328.4A CN103980317B (en) 2014-05-28 2014-05-28 Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN103980317A CN103980317A (en) 2014-08-13
CN103980317B true CN103980317B (en) 2017-01-25

Family

ID=51272509

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410242328.4A Active CN103980317B (en) 2014-05-28 2014-05-28 Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN103980317B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6178611B2 (en) * 2013-05-08 2017-08-09 Jxtgエネルギー株式会社 Method for producing ester compound
EP3256250B1 (en) 2015-02-10 2020-06-24 Council of Scientific and Industrial Research Phenanthroline based pincer complexes useful as catalysts for the preparation of methanol from carbondioxide
CN109956970A (en) * 2017-12-26 2019-07-02 南开大学 Biphenyl type tridentate ligand ruthenium complex and its preparation method and application
US11098074B2 (en) 2018-02-09 2021-08-24 Takasago International Corporation Chiral tetradentate ligand, method for producing same and transition metal complex of said chiral tetradentate ligand
CN108704665B (en) * 2018-06-20 2021-02-26 海南师范大学 Application of tris (2,2' -bipyridyl) ruthenium (II) chloride hexahydrate as catalyst
CN111185241B (en) * 2020-03-09 2022-08-02 邯郸学院 Metal catalyst and preparation method and application thereof
CN114436949B (en) * 2022-01-25 2023-09-22 上海巽田科技股份有限公司 Tetradentate ligand, metal complex, and preparation methods and applications thereof
CN114656501B (en) * 2022-04-25 2024-03-19 成都欣华源科技有限责任公司 2,2' -bipyridine skeleton biphosphine ligand, and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1561261A (en) * 2001-08-01 2005-01-05 加州理工学院 Hexacoordinated ruthenium or osmium metal carbene metathesis catalysts
CN1876632A (en) * 2006-07-07 2006-12-13 中国科学院长春应用化学研究所 Solid phase time identification fluorescent immunity analysis chelant and its preparation method
EP1970360A1 (en) * 2007-03-16 2008-09-17 Takasago International Corporation Method for producing alcohols
CN101671218A (en) * 2008-09-09 2010-03-17 高砂香料工业株式会社 Alcohol production method by reducing ester or lactone with hydrogen
CN101142155B (en) * 2005-04-05 2011-06-01 弗门尼舍有限公司 Hydrogenation of esters with ru/tetradentate ligands complexes
WO2012102247A1 (en) * 2011-01-24 2012-08-02 国立大学法人名古屋大学 Ruthenium complex-containing catalyst for hydrogen transfer reaction and method for producing hydrogen transfer reaction product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9045381B2 (en) * 2010-10-19 2015-06-02 Yeda Research And Development Co. Ltd. Ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1561261A (en) * 2001-08-01 2005-01-05 加州理工学院 Hexacoordinated ruthenium or osmium metal carbene metathesis catalysts
CN101142155B (en) * 2005-04-05 2011-06-01 弗门尼舍有限公司 Hydrogenation of esters with ru/tetradentate ligands complexes
CN1876632A (en) * 2006-07-07 2006-12-13 中国科学院长春应用化学研究所 Solid phase time identification fluorescent immunity analysis chelant and its preparation method
EP1970360A1 (en) * 2007-03-16 2008-09-17 Takasago International Corporation Method for producing alcohols
CN101671218A (en) * 2008-09-09 2010-03-17 高砂香料工业株式会社 Alcohol production method by reducing ester or lactone with hydrogen
WO2012102247A1 (en) * 2011-01-24 2012-08-02 国立大学法人名古屋大学 Ruthenium complex-containing catalyst for hydrogen transfer reaction and method for producing hydrogen transfer reaction product

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"A new family of aromatic polyimine chelates substituted with two diphenylphosphines";Ziessel, R.;《Tetrahedron Letters》;19891231;第30卷(第4期);463-466 *
A preliminary investigation into a rationally designed catalytic system for the epoxidation of alkenes based on a bipyridyl core;Gennadiy Ilyashenko等;《Journal of Molecular Catalysis A: Chemical》;20081231;第296卷(第1-2期);1-8 *
New and improved catalysts for transition metal catalysed radical reactions;floryan de campo等;《Chem. Commun.》;19981231(第19期);2117-2118 *
Stepwise Metal–Ligand Cooperation by a Reversible Aromatization/Deconjugation Sequence in Ruthenium Complexes with a Tetradentate Phenanthroline-Based Ligand;Robert Langer,等;《Chem.Eur.J.》;20130304;第19卷(第10期);3407-3414 *

Also Published As

Publication number Publication date
CN103980317A (en) 2014-08-13

Similar Documents

Publication Publication Date Title
CN103980317B (en) Dipyridyl tetradentate ligand ruthenium complex as well as preparation method and application thereof
CN102858788B (en) Ruthenium complex and the method preparing optical activity alkylol cpd
CN106458823B (en) Process for preparing unsaturated carboxylic acid salts
Crabtree et al. Cationic iridium diolefin complexes as alkene hydrogenation catalysts and the isolation of some related hydrido complexes
CN106892935B (en) A kind of immobilized copper catalysis of chitosan prepares the method and application of organoboron compound
CN101671218B (en) Alcohol production method by reducing ester or lactone with hydrogen
US20170022138A1 (en) Butyl-bridged diphosphine ligands for alkoxycarbonylation
CN107573370A (en) The method that supported copper ion chitosan microball catalysis prepares organoboron compound and β hydroxy compounds
CN109956970A (en) Biphenyl type tridentate ligand ruthenium complex and its preparation method and application
AU685660B2 (en) Heteroaromatic diphosphines as chiral ligands
CA2973839C (en) 1,1'-bis(phosphino)ferrocene ligands for alkoxycarbonylation
Hennig et al. Synthesis of (R)-and (S)-4-hydroxyisophorone by ruthenium-catalyzed asymmetric transfer hydrogenation of ketoisophorone
Kusy et al. Ligand-free (Z)-selective transfer semihydrogenation of alkynes catalyzed by in situ generated oxidizable copper nanoparticles
Gladiali et al. Optically active phenanthrolines in asymmetric catalysis. III. Highly efficient enantioselective transfer hydrogenation of acetophenone by chiral rhodium/3-alkyl phenanthroline catalysts.
Bandari et al. Deoxygenative Transition-Metal-Promoted Reductive Coupling and Cross-Coupling of Alcohols and Epoxides
CN114436949A (en) Tetradentate ligand and metal complex, and preparation method and application thereof
Joseph et al. Cationic half-sandwich ruthenium (II) complexes ligated by pyridyl-triazole ligands: Transfer hydrogenation and mechanistic studies
JP2012504596A (en) Hydrogenation of ester or carbonyl groups with phosphinooxide-based ruthenium complexes
CN109096318A (en) The method that load copper ion Y type molecular sieve catalysis prepares organoboron compound and beta-hydroxy compound
CN103958451B (en) The method of 2-chain olefine aldehydr, particularly isoamyl olefine aldehydr that preparation 3-replaces
Muthusamy et al. Efficient synthesis of 19–31 membered macrocyclic tetralactones via ring closing metathesis in ionic liquids
CN103554022B (en) A kind of synthetic method of Higenamine hydrochloride
CA2973697C (en) 1,1'-bis(phosphino)ferrocene ligands for alkoxycarbonylation
Stolyarov et al. Catalytic hydroallylation of norbornadiene with allyl formate
CN109824600A (en) A kind of method of the asymmetric hydrogenation synthesis of chiral ring-type urea of palladium chtalyst 2- hydroxypyrimidine compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant